{
    "SPADE_UN_13871": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13871",
            "Peptide Name": "P6(ACE2 (4-26)-G-ACE2 (333-339))",
            "Source": "Synthetic construct(derived from angiotensin-converting enzyme 2)",
            "Family": "Coronaviridae",
            "Gene": "Not found",
            "Sequence": "EEQAKTFLDKFNHEAEDLFYQSSGLGKGDFR",
            "Sequence Length": 31,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/Q9BYF1"
            ],
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.16510163]SARS-CoV:inhibition of pseudovirus infection in HeLa cells(IC50=0.1 ÂµM).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "No cytotoxicity information or data found in the reference(s) presented in this entry",
            "Binding Target": "spike glycoprotein",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C161H236N42O53",
            "Mass": 3607.85,
            "PI": 4.7,
            "Net Charge": -2,
            "Hydrophobicity": -1.06,
            "Half Life": "Mammalian:1 hourYeast:30 minE.coli:>10 hour",
            "Mechanism of action": "Virus entry into cells is mediated through interactions between spike (S) glycoprotein and angiotensin-converting enzyme 2 (ACE2), peptide derived from ACE2 could bind with spike glycoprotein and inhibits virus entry.",
            "Literature": [
                {
                    "Title": "Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.",
                    "Pubmed ID": "16510163",
                    "Reference": "Virology. 2006 Jun 20;350(1)15-25.",
                    "Author": "Han DP, Penn-Nicholson A, Cho MW.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16510163"
                }
            ],
            "Frequent Amino Acids": "EFD",
            "Absent Amino Acids": "CIMOPUVW",
            "Basic Residues": 5,
            "Acidic Residues": 7,
            "Hydrophobic Residues": 10,
            "Polar Residues": 14,
            "Positive Residues": 5,
            "Negative Residues": 7,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_13873",
                    "Similarity": 1.0,
                    "Sequence": "EEQAKTFLDKFNHEAEDLFYQSS"
                },
                {
                    "SPADE_ID": "SPADE_UN_13876",
                    "Similarity": 1.0,
                    "Sequence": "EEQAKTFLDK"
                },
                {
                    "SPADE_ID": "SPADE_UN_13538",
                    "Similarity": 1.0,
                    "Sequence": "QAKTFLDKFNHEA"
                }
            ]
        }
    }
}